We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MCO:NYSEMoody's Corporation Analysis

Data as of 2026-09-01 - not real-time

$504.64

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Moody's Corporation is bullish at $504.64, with short-term averages leading the long-term ones. Relative strength is 57.1 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $470.53 and resistance at $520.67.
Multiples put this in overvalued territory: 32.7 times earnings against the sector's 16.9. Consensus targets land 11.1% above where the shares trade now. Revenue is growing at 15.1% on a 34.3% profit margin. The 0.80% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 23.9%, a beta of 0.49 and a maximum drawdown of 23.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 2/10 conviction over the longer horizon.

Top Market Events

The end of the earnings season is always a good time to take a step back and see who shined and who didn’t .Intapp, Inc. and Moody's Corporation NYSE:MCO are expanding their partnership to integrate Moody's financial risk...NEW YORK, August 12, 2026--Moody’s Corporation NYSE:MCO today announced that Keith Demmings has been elected to the...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 472.82
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 32.7 versus sector average of 16.9
  • Trading above the 200-day average of 472.82

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 32.7 versus sector average of 16.9
  • Analyst targets imply +11.1% versus the current price
  • Profit margin of 34.3% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth15.10%
Profit Margin34.25%
P/E Ratio32.7
ROE76.93%
ROA15.62%
Debt/Equity240.68
P/B Ratio28.9
Op. Cash Flow$3.3B
Free Cash Flow$2.6B
Industry P/E16.9

Technical Analysis

TrendBullish
RSI57.1
Support$470.53
Resistance$520.67
MA 20$492.70
MA 50$485.18
MA 200$472.82
MACDBullish
VolumeStable
Fear & Greed Index93.89

Valuation

Fair Value$318.88
Target Price$560.48
Upside/Downside11.06%
GradeOvervalued
TypeGrowth
Dividend Yield0.80%

Risk Assessment

Beta0.49
Volatility23.92%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.